First Trust Advisors LP Fate Therapeutics Inc Transaction History

First Trust Advisors LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$17.78 - $42.39 $192,681 - $459,380	-10,837 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$29.67 - $60.28 $321,533 - $653,254	10,837 New	10,837 $420,000
Q4 2021 Feb 08, 2022	SELL	$47.84 - $64.34 $2.18 Million - $2.94 Million	-45,618 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$59.27 - $95.73 $825,334 - $1.33 Million	-13,925 Reduced 23.39%	45,618 $2.7 Million
Q2 2021 Aug 16, 2021	SELL	$67.25 - $92.52 $918,971 - $1.26 Million	-13,665 Reduced 18.67%	59,543 $5.17 Million
Q1 2021 May 14, 2021	SELL	$72.16 - $117.4 $2.53 Million - $4.12 Million	-35,117 Reduced 32.42%	73,208 $6.04 Million
Q4 2020 Feb 02, 2021	BUY	$38.09 - $100.95 $1.58 Million - $4.18 Million	41,427 Added 61.93%	108,325 $9.85 Million
Q3 2020 Nov 05, 2020	SELL	$30.41 - $40.5 $422,121 - $562,180	-13,881 Reduced 17.18%	66,898 $2.67 Million
Q2 2020 Jul 22, 2020	SELL	$20.21 - $35.23 $411,414 - $717,177	-20,357 Reduced 20.13%	80,779 $2.77 Million
Q1 2020 May 06, 2020	BUY	$17.28 - $31.88 $1.39 Million - $2.57 Million	80,566 Added 391.67%	101,136 $2.25 Million
Q4 2019 Feb 03, 2020	SELL	$13.39 - $20.73 $2.2 Million - $3.4 Million	-164,130 Reduced 88.86%	20,570 $403,000
Q3 2019 Nov 04, 2019	BUY	$15.47 - $22.5 $778,326 - $1.13 Million	50,312 Added 37.44%	184,700 $2.87 Million
Q2 2019 Jul 30, 2019	BUY	$15.61 - $20.44 $2.1 Million - $2.75 Million	134,388 New	134,388 $2.73 Million

175

115M

53.7K

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $215M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

Stay updated on First Trust Advisors LP with notifications on news.